Their results showed that CA inhibited the proliferation of breast cancer cells, reducing the growth of breast cancer cells through modulating ER and IGFIR levels, thereby influencing downstream effectors and cell-cycle progression, but better CA activity in the MCF-7 cells (estrogen-positive) was observed. The gene discussed is ESR1; the disease is breast cancer.